Neuropeptides: opportunities for drug discovery

By Hokfelt T.   Bartfai T.   Bloom F.  

Lancet Neurology, Vol. 2, Iss. 8, 2003-08 ,pp. : 463-472

Elsevier

Access to resources Recommend Favorite

Validation of the Neuroinflammation Cycle as a Drug Discovery Target Using Integrative Chemical Biology and Lead Compound Development with an Alzheimer's Disease-Related Mouse Model

By  

Current Alzheimer Research, Vol. 2, Iss. 2, 2005-04 ,pp. : 197-205

Bentham Science Publishers

Access to resources Recommend Favorite

Role of Functional Magnetic Resonance Imaging in Drug Discovery

By Paulus Martin   Stein Murray  

Neuropsychology Review, Vol. 17, Iss. 2, 2007-06 ,pp. : 179-188

Springer Publishing Company

Access to resources Recommend Favorite

Drug discovery for Alzheimer’s disease: The end of the beginning

By Refolo Lorenzo   Fillit Howard  

Journal of Molecular Neuroscience, Vol. 24, Iss. 1, 2004-02 ,pp. : 1-8

Humana Press, Inc

Access to resources Recommend Favorite

Strategies for Drug Discovery for Cognitive Aging and Alzheimer's Disease

By Fillit H.M.   O'Connell A.W.   Refolo L.M.  

Journal of Molecular Neuroscience, Vol. 19, Iss. 1-2, 2002-10 ,pp. : 1-6

Humana Press, Inc

Access to resources Recommend Favorite